{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:43:45Z","timestamp":1771861425853,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106703","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T02:23:30Z","timestamp":1631067810000},"page":"106703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement"],"prefix":"10.1016","volume":"111","author":[{"given":"Mohsen","family":"Esfandbod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedeh","family":"Enshaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-1626","authenticated-orcid":false,"given":"Seyed Mostafa","family":"Monzavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Kabootari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-079X","authenticated-orcid":false,"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.leukres.2021.106703_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG E2993","volume":"108","author":"Lazarus","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0010","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2011.01.031","article-title":"Disclosing the mysteries of the central nervous system sanctuary for acute lymphoblastic leukemia cells","volume":"35","author":"Pistoia","year":"2011","journal-title":"Leuk. Res."},{"issue":"11","key":"10.1016\/j.leukres.2021.106703_bib0020","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2021.106703_bib0025","series-title":"Williams Hematology","first-page":"1505","article-title":"Acute lymphoblastic leukemia","author":"Larson","year":"2016"},{"issue":"10","key":"10.1016\/j.leukres.2021.106703_bib0030","first-page":"CD008818","article-title":"Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission","author":"Pidala","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.leukres.2021.106703_bib0035","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"588","article-title":"Hematopoietic cell transplantation for acute lymphoblastic leukemia in adults","author":"Forman","year":"2016"},{"issue":"2","key":"10.1016\/j.leukres.2021.106703_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5812\/ircmj.1915","article-title":"Twenty years of experience on stem cell transplantation in Iran","volume":"15","author":"Ghavamzadeh","year":"2013","journal-title":"Iran. Red Crescent Med. J."},{"issue":"12","key":"10.1016\/j.leukres.2021.106703_bib0045","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.bbmt.2017.08.036","article-title":"Outcome analysis of pediatric patients with acute lymphoblastic leukemia treated with total body irradiation-free allogeneic hematopoietic stem cell transplantation: comparison of patients with and without central nervous system involvement","volume":"23","author":"Hamidieh","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0050","first-page":"1","article-title":"Allogeneic stem cell transplantation outcome in acute lymphoblastic leukemia patients","volume":"6","author":"Alimoghaddam","year":"2012","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.leukres.2021.106703_bib0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.critrevonc.2018.01.011","article-title":"Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: a review","volume":"123","author":"Paix","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2021.106703_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37549\/ARO1097","article-title":"Total body irradiation: a practical review","volume":"5","author":"Wills","year":"2016","journal-title":"Appl. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.leukres.2008.10.003","article-title":"Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT","volume":"33","author":"Konuma","year":"2009","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.12239","article-title":"Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission","volume":"161","author":"Hochberg","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5144\/1658-3876.2011.17","article-title":"Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis","volume":"4","author":"Gupta","year":"2011","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"issue":"28","key":"10.1016\/j.leukres.2021.106703_bib0085","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1200\/JCO.2013.48.8114","volume":"31","author":"Nagler","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2021.106703_bib0090","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bbmt.2019.04.012","article-title":"Worldwide network for blood and marrow transplantation recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources, part II: clinical, technical, and socioeconomic considerations","volume":"25","author":"Aljurf","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.leukres.2021.106703_bib0095","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbmt.2012.02.016","article-title":"Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity","volume":"18","author":"Christopoulos","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2021.106703_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/tro.2018.07.04","article-title":"Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation","volume":"2","author":"Kuo","year":"2018","journal-title":"Ther. Radiol. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106703_bib0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbmt.2015.10.016","article-title":"Implications and management of central nervous system involvement before allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia","volume":"22","author":"Aldoss","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.leukres.2021.106703_bib0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbmt.2017.11.013","article-title":"Augmenting total body irradiation with a cranial boost before stem cell transplantation protects against post-transplant central nervous system relapse in acute lymphoblastic leukemia","volume":"24","author":"Gao","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"16","key":"10.1016\/j.leukres.2021.106703_bib0115","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.2006.10.0677","article-title":"Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm","volume":"25","author":"Gerstner","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4 Suppl 2","key":"10.1016\/j.leukres.2021.106703_bib0120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous system disease in hematologic malignancies: historical perspective and practical applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.leukres.2021.106703_bib0125","series-title":"Perez and Brady\u2019S Principles and Practice of Radiation Oncology","first-page":"1586","article-title":"Leukemia","author":"Roberts","year":"2013"},{"issue":"5","key":"10.1016\/j.leukres.2021.106703_bib0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1179\/102453308X343374","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia","volume":"13","author":"Thomas","year":"2008","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2018.05.067","article-title":"Radiation in central nervous system leukemia: guidelines from the international lymphoma radiation oncology group","volume":"102","author":"Pinnix","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.leukres.2021.106703_bib0140","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.25008","article-title":"Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies","volume":"116","author":"Jabbour","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2021.106703_bib0145","series-title":"Williams Hematology","first-page":"1409","article-title":"Acute lymphoblastic leukemia","author":"Pui","year":"2010"},{"issue":"11","key":"10.1016\/j.leukres.2021.106703_bib0150","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT\u2212NIH\u2212CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.leukres.2021.106703_bib0155","series-title":"Blood and Marrow Transplant Handbook","first-page":"161","article-title":"Engraftment","author":"Murray","year":"2015"},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/bmt.2015.305","article-title":"Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission","volume":"51","author":"Ruggeri","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"19","key":"10.1016\/j.leukres.2021.106703_bib0165","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1182\/blood-2011-07-363333","article-title":"Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples","volume":"118","author":"Ethier","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2021.106703_bib0170","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bbmt.2010.02.003","article-title":"Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source","volume":"16","author":"Ferra","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0175","first-page":"485","article-title":"[Treatment and prognosis of adult t cell acute lymphoblastic leukemia]","volume":"41","author":"Huang","year":"2019","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"12","key":"10.1016\/j.leukres.2021.106703_bib0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/bmt.2008.258","article-title":"Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy","volume":"42","author":"Terwey","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.leukres.2021.106703_bib0185","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00277-018-3383-9","article-title":"Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study","volume":"97","author":"Sakellari","year":"2018","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0190","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbmt.2017.11.025","article-title":"Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia","volume":"24","author":"Kebriaei","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"20","key":"10.1016\/j.leukres.2021.106703_bib0195","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"Thomas","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2021.106703_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2019.08.005","article-title":"Comparison of different conditioning regimens in allogeneic hematopoietic stem-cell transplantation shows superiority of total body irradiation-based regimen for younger patients with acute leukemia: a nationwide study","volume":"19","author":"Park","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.leukres.2021.106703_bib0205","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","first-page":"99","article-title":"Conditioning","author":"Nagler","year":"2019"},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41409-018-0373-4","volume":"54","author":"Giebel","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.leukres.2021.106703_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2019.08.005","article-title":"Total body irradiation-based versus chemotherapy-based myeloablative conditioning for allogeneic hematopoietic cell transplant","volume":"25","author":"Storb","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2021.106703_bib0220","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2016.00470","article-title":"Milestones of hematopoietic stem cell transplantation - from first human studies to current developments","volume":"7","author":"Juric","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2021.106703_bib0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation.V2012.1.237.3798315","article-title":"Do different conditioning regimens really make a difference?","volume":"2012","author":"Blaise","year":"2012","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.leukres.2021.106703_bib0230","article-title":"Central Nervous System Relapse After Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: A Single-Institution Experience","author":"Kozak","year":"2019","journal-title":"J. Adolesc. Young Adult Oncol."},{"issue":"10","key":"10.1016\/j.leukres.2021.106703_bib0235","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2008.07.002","article-title":"Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Oshima","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.leukres.2021.106703_bib0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.14411","article-title":"Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy","volume":"176","author":"Frishman-Levy","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/bjh.12598","article-title":"Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study","volume":"164","author":"Alloin","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11912-009-0073-8","article-title":"Modern multidisciplinary management of brain metastases","volume":"12","author":"Thomas","year":"2010","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.leukres.2021.106703_bib0255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OTT.S78567","article-title":"Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Chen","year":"2015","journal-title":"Onco. Targets Ther."},{"issue":"1","key":"10.1016\/j.leukres.2021.106703_bib0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41409-018-0221-6","article-title":"Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia","volume":"54","author":"Kato","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2018.02.012","article-title":"Risk factors influencing outcome of acute leukemia patients who experience relapse after allogeneic hematopoietic stem-cell transplantation","volume":"18","author":"El-Ghammaz","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"10","key":"10.1016\/j.leukres.2021.106703_bib0270","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106703_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2017.05.011","article-title":"Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia","volume":"59","author":"Tan","year":"2017","journal-title":"Leuk. Res."},{"issue":"11","key":"10.1016\/j.leukres.2021.106703_bib0280","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bbmt.2014.07.005","article-title":"Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Hamdi","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.leukres.2021.106703_bib0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12185-017-2197-1","article-title":"Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL working Group of the Japan Society for Hematopoietic Cell Transplantation","volume":"105","author":"Shigematsu","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2021.106703_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106666","article-title":"Philadelphia-positive B-lymphoblastic leukemia in a middle-income country - A real-world multicenter cohort","volume":"110","author":"Silva","year":"2021","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.leukres.2021.106703_bib0295","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","article-title":"Philadelphia-positive acute lymphoblastic leukemia: current treatment options","volume":"14","author":"Liu-Dumlao","year":"2012","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.leukres.2021.106703_bib0300","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.leukres.2008.04.011","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and\/or at first relapse: results from the GET-LALA group","volume":"32","author":"Reman","year":"2008","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0305","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.2012.09095.x","article-title":"Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII\/ECOG2993 trial","volume":"157","author":"Sive","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106703_bib0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3324\/haematol.2009.010306","article-title":"Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia","volume":"95","author":"Maury","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2021.106703_bib0315","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.clml.2018.02.013","article-title":"Prognostic effect of CD20 expression in adult B-cell acute lymphoblastic leukemia","volume":"18","author":"Esteban","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"4","key":"10.1016\/j.leukres.2021.106703_bib0320","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2011.054064","article-title":"CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease","volume":"97","author":"Mannelli","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2021.106703_bib0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.leukres.2018.03.001","article-title":"No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia","volume":"68","author":"Dai","year":"2018","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2021.106703_bib0330","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/102453312X13221316477741","article-title":"CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value","volume":"17","author":"Solano-Genesta","year":"2012","journal-title":"Hematology"},{"issue":"19","key":"10.1016\/j.leukres.2021.106703_bib0335","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2011-01-329573","article-title":"Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia","volume":"117","author":"Bachanova","year":"2011","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:31Z","timestamp":1758934951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":67,"alternative-id":["S0145212621002046"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106703","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106703"}}